Pentraxin 3 (PTX3) and complement component C1q are humoral factors of innate immunity, produced at sites of inflammation, and are essential in immune defense against several microbes such as Aspergillus, which is commonly implicated in nasal polyposis.
Methods
PTX3 and C1q were measured in nasal polyp tissue, normal nasal mucosa, and serum of patients and healthy subjects. Immunohistochemistry for the two proteins was done on normal nasal mucosa and nasal polyps. In addition, PTX3 and C1q production from mononuclear cells from patients and healthy subjects was assessed.
Results
Normal nasal mucosa was found to have 100-fold higher levels of PTX3 compared with serum. No measurable local increase of PTX3 was observed in polyps compared with normal mucosa. Immunohistochemistry revealed PTX3 expression in the lining of blood vessels both within normal mucosa and nasal polyps. PTX3 also was present in mononuclear cells infiltrating nasal polyps. C1q levels were higher in polyps than in normal nasal mucosa.
Conclusion
High levels of PTX3 are present in normal nasal mucosa, suggesting a role in the maintenance of tissue homeostasis. Elevated C1q levels in nasal polyps might be indicative of an ongoing inflammatory response in the nasal mucosa in these patients.
WaxmanJ.E., SpectorJ.G., SaleS.R.Allergic Aspergillus sinusitis: Concepts in diagnosis and treatment of a new clinical entity.Laryngoscope97: 261–266, 1987.
4.
PonikauJ.U., SherrisD.A., KernE.B.The diagnosis and incidence of allergic fungal sinusitis.Mayo Clin Proc74: 877–884, 1999.
5.
ShinS.H., PonikauJ.U., SherrisD.A.Chronic rhinosinusitis: An enhanced immune response to ubiquitous airborne fungi.J Allergy Clin Immunol114: 1369–1375, 2004.
6.
WeschtaM., RimekD., FormanekM.Local production of Aspergillus fumigatus specific immunoglobulin E in nasal polyps.Laryngoscope113: 1798–1802, 2003.
ConleyD.B., TripathiA., DittoA.M.Chronic sinusitis with nasal polyps: Staphylococcal exotoxin immunoglobulin E and cellular inflammation.Am J Rhinol18: 273–278, 2004.
9.
BottoM., and WalportM.J.C1q, autoimmunity and apoptosis.Immunobiology205: 395–406, 2002.
10.
KishoreU., GaboriaudC., WatersP.C1q and tumor necrosis factor superfamily: Modularity and versatility.Trends Immunol25: 551–561, 2004.
11.
GarlandaC., BottazziB., BastoneA.Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertility.Annu Rev Immunol23: 337–366, 2005.
12.
GarlandaC., HirschE., BozzaS.Non-redundant role of the long pentraxin PTX3 in anti-fungal innate immune response.Nature420: 182–186, 2002.
13.
BaruahP., DumitriuI.E., PeriG.The tissue pentraxin PTX3 limits C1q-mediated complement activation and phagocytosis of apoptotic cells by dendritic cells.J Leukoc Biol80: 87–95, 2006.
14.
BaruahP., PropatoA., DumitriuI.E.The pattern recognition receptor PTX3 is recruited at the synapse between dying and dendritic cells and edits the cross-presentation of self, viral, and tumor antigens.Blood15: 15, 2005.
15.
RovereP., PeriG., FazziniF.The long pentraxin PTX3 binds to apoptotic cells and regulates their clearance by antigen-presenting dendritic cells.Blood96: 4300–4306, 2000.
16.
SallustoF., and LanzavecchiaA.Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha.J Exp Med179: 1109–1118, 1994.
17.
RescignoM., UrbanoM., ValzasinaB.Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria.Nat Immunol2: 361–367, 2001.
18.
DoniA., PeriG., GhieppaM.Production of the soluble pattern recognition receptor PTX3 by myeloid, but not plasmacytoid, dendritic cells.Eur J Immunol33: 2886–2893, 2003.
19.
AntesU., HeinzH.P., and LoosM.Enzyme-linked immunosorbent assay for C1q in human serum by use of monoclonal antibodies.J Immunol Methods74: 299–306, 1984.
20.
FazziniF., PeriG., DoniA.PTX3 in small-vessel vasculitides: An independent indicator of disease activity produced at sites of inflammation.Arthritis Rheum44: 2841–2850, 2001.
21.
BernsteinJ.M., BallowM., RichG.Lymphocyte subpopulations and cytokines in nasal polyps: Is there a local immune system in the nasal polyp?Otolaryngol Head Neck Surg130: 526–535, 2004.
22.
BernsteinJ.M., and KansalR.Superantigen hypothesis for the early development of chronic hyperplastic sinusitis with massive nasal polyposis.Curr Opin Otolaryngol Head Neck Surg13: 39–44, 2005.
23.
FinottoS., OhnoI., MarshallJ.S.TNF-alpha production by eosinophils in upper airways inflammation (nasal polyposis).J Immunol153: 2278–2289, 1994.
24.
ChenP.H., and FangS.Y.Expression of human beta-defensin 2 in human nasal mucosa.Eur Arch Otorhinolaryngol261: 238–241, 2004.
25.
VandermeerJ., ShaQ., LaneA.P.Innate immunity of the sinonasal cavity: Expression of messenger RNA for complement cascade components and toll-like receptors.Arch Otolaryngol Head Neck Surg130: 1374–1380, 2004.
26.
AkbariO., DeKruyffR.H., and UmetsuD.T.Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen.Nat Immunol2: 725–731, 2001.
27.
MedzhitovR.Toll-like receptors and innate immunity.Nat Rev Immunol1: 135–145, 2001.
28.
RomaniL.Immunity to fungal infections.Nat Rev Immunol4: 1–23, 2004.
29.
CastellanoG., WoltmanA.M., NautaA.J.Maturation of dendritic cells abrogates C1q production in vivo and in vitro.Blood103: 3813–3820, 2004.
LeighL.E., GhebrehiwetB., PereraT.P.C1q-mediated chemotaxis by human neutrophils: Involvement of gClqR and G-protein signalling mechanisms.Biochem J330: 247–254, 1998.
32.
KramerM.F., and RaspG.Nasal polyposis: Eosinophils and interleukin-5.Allergy54: 669–680, 1999.
